Philip J. Gold
Experienced in Myxoid Liposarcoma

Dr. Philip J. Gold

Oncology
Swedish Medical Center
Medical Oncology - Swedish Cancer Institute First Hill
1221 Madison Street, 0, 
Seattle, WA 
Accepting New Patients
Offers Telehealth

Experienced in Myxoid Liposarcoma
Swedish Medical Center
Medical Oncology - Swedish Cancer Institute First Hill
1221 Madison Street, 0, 
Seattle, WA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Dr. Gold is a multiple time recipient of the Seattle Top Doctor Award and most recently received the 2024 Seattle Magazine Top Doc Award. Dr. Gold is Director of Clinical Research and the Program Leader for the Gastrointestinal (GI) Oncology Program at the Swedish Cancer Institute in Seattle, Washington. In 1991, Dr. Gold obtained his degree in medicine with a distinction in research at the University of Miami School of Medicine in Florida. He then completed an internal medicine internship and residency at the University of Washington. Dr. Gold received the Amgen Oncology Fellowship Award while he was training in medical oncology at the University of Washington School of Medicine and the Fred Hutchinson Cancer Research Center. Presently, he is board certified in medical oncology. Dr. Gold’s clinical investigations on GI tumors, and particularly colorectal cancer treatment, can be found in peer-reviewed publications like the Journal of Clinical Oncology, Seminars in Oncology, and Cancer Investigation. Furthermore, he currently serves as a member of the NCI Colon Task Force, and the Southwest Oncology Group, where he serves as the subcommittee co-chair for colon cancer. In his free time, Dr. Gold enjoys photography and spending time with his wife and three sons.

Dr. Gold is rated as an Experienced provider by MediFind in the treatment of Myxoid Liposarcoma. His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Neuroendocrine Tumor, and Lynch Syndrome.

His clinical research consists of co-authoring 20 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
University Of Miami Leonard M. Miller School Of Medicine , 1991
Residency
Veterans Administration Medical Center , 1997
Specialties
Oncology
Licenses
Internal Medicine in WA
Board Certifications
American Board Of Internal Medicine
Fellowships
University of Washington School of Medicine , 1997
Hospital Affiliations
Swedish Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Community Health
  • EPO
  • HMO
Coordinated Care
  • HMO
  • MANAGED MEDICAID PLAN
Group Health Cooperative
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
PacificSource
  • PPO
Premera
  • EPO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Prominence Health
  • EPO
  • PPO
Regence
  • EPO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 16 Less Insurance Carriers -

Locations

Medical Oncology - Swedish Cancer Institute First Hill
1221 Madison Street, 0, Seattle, WA 98104
Call: 206-386-3751
Other Locations
Swedish Cherry Hill
500 17th Avenue, Seattle, WA 98122
Call: 206-320-2000
Swedish First Hill
747 Broadway, Seattle, WA 98122
Call: 206-386-6000

Additional Areas of Focus

Dr. Gold has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Lynch Syndrome
Gallbladder Cancer
Pseudomyxoma Peritonei
Insulinoma
Colorectal Cancer
Anal Cancer
Gastroesophageal Junction Cancer
Hepatoblastoma
Stomach Cancer
Breast Cancer

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


5 Clinical Trials

Phase 1 Study of VE800 and Nivolumab in Patients With Selected Types of Advanced or Metastatic Cancer
Phase 1 Study of VE800 and Nivolumab in Patients With Selected Types of Advanced or Metastatic Cancer
Enrollment Status: Completed
Publish Date: October 27, 2025
Intervention Type: Drug, Biological
Study Phase: Phase 1/Phase 2
A Phase 1b/2, Open Label, Dose Escalation Study of Margetuximab in Combination With Pembrolizumab in Patients With Relapsed/Refractory Advanced HER2+ Gastroesophageal Junction or Gastric Cancer
A Phase 1b/2, Open Label, Dose Escalation Study of Margetuximab in Combination With Pembrolizumab in Patients With Relapsed/Refractory Advanced HER2+ Gastroesophageal Junction or Gastric Cancer
Enrollment Status: Completed
Publish Date: March 17, 2025
Intervention Type: Biological
Study Drug: Margetuximab+Pembrolizumab
Study Phase: Phase 1/Phase 2
A Phase II Study (With Safety run-in) of Evorpacept (ALX148) in Combination With Cetuximab and Pembrolizumab in Patients With Refractory Microsatellite Stable Metastatic Colorectal Cancer
A Phase II Study (With Safety run-in) of Evorpacept (ALX148) in Combination With Cetuximab and Pembrolizumab in Patients With Refractory Microsatellite Stable Metastatic Colorectal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: January 13, 2025
Intervention Type: Drug
Study Drugs: ALX148, Cetuximab, Pembrolizumab
Study Phase: Phase 2
Phase II Pilot Study of FOLFOXIRI Plus Panitumumab in Metastatic RAS Wild-type, Left-sided Colorectal Cancer
Phase II Pilot Study of FOLFOXIRI Plus Panitumumab in Metastatic RAS Wild-type, Left-sided Colorectal Cancer
Enrollment Status: Unknown
Publish Date: July 27, 2023
Intervention Type: Drug
Study Phase: Phase 2
A Phase II, Multicenter, Single-Arm Study of Oral Ceritinib in Adult Patients With ALK and ROS1 Activated Gastrointestinal Malignancies
A Phase II, Multicenter, Single-Arm Study of Oral Ceritinib in Adult Patients With ALK and ROS1 Activated Gastrointestinal Malignancies
Enrollment Status: Terminated
Publish Date: April 02, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 4 Less Clinical Trials

20 Total Publications

Rechallenge With an Epidermal Growth Factor Receptor Inhibitor in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis.
Rechallenge With an Epidermal Growth Factor Receptor Inhibitor in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis.
Journal: JCO oncology practice
Published: December 15, 2025
View All 20 Publications
Similar Doctors
Distinguished in Myxoid Liposarcoma
Dr. Elizabeth T. Loggers
Oncology | Hematology
Distinguished in Myxoid Liposarcoma
Dr. Elizabeth T. Loggers
Oncology | Hematology

The Association Of University Physicians

825 Eastlake Ave E, 
Seattle, WA 
 (1.2 miles away)
206-288-1000
Languages Spoken:
English, Korean, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Elizabeth Loggers is an Oncologist and a Hematologist in Seattle, Washington. Dr. Loggers is rated as an Elite provider by MediFind in the treatment of Myxoid Liposarcoma. Her top areas of expertise are Adult Soft Tissue Sarcoma, Epithelioid Sarcoma, Liposarcoma, Angiosarcoma, and Liver Embolization. Dr. Loggers is currently accepting new patients.

Advanced in Myxoid Liposarcoma
Dr. Sara J. Grethlein
Hematology Oncology | Oncology
Advanced in Myxoid Liposarcoma
Dr. Sara J. Grethlein
Hematology Oncology | Oncology
1221 Madison St, 2nd Fl, 
Seattle, WA 
 (0.1 miles away)
206-386-2323
Languages Spoken:
English, Spanish, Telugu
See accepted insurances
Accepting New Patients
Offers Telehealth

Sara Grethlein is a Hematologist Oncology specialist and an Oncologist in Seattle, Washington. Dr. Grethlein is rated as an Advanced provider by MediFind in the treatment of Myxoid Liposarcoma. Her top areas of expertise are Multiple Myeloma, Myxoid Liposarcoma, Glioma, and Liposarcoma. Dr. Grethlein is currently accepting new patients.

Advanced in Myxoid Liposarcoma
Dr. Min S. Park
Oncology
Advanced in Myxoid Liposarcoma
Dr. Min S. Park
Oncology

The Association Of University Physicians

825 Eastlake Ave E, 
Seattle, WA 
 (1.2 miles away)
206-288-1000
Languages Spoken:
English, Castilian, Japanese, Korean, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Min Park is an Oncologist in Seattle, Washington. Dr. Park is rated as a Distinguished provider by MediFind in the treatment of Myxoid Liposarcoma. Her top areas of expertise are Nasopharyngeal Carcinoma, Melanoma, Ampullary Cancer, Liposarcoma, and Osteotomy. Dr. Park is currently accepting new patients.

VIEW MORE MYXOID LIPOSARCOMA DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Gold's expertise for a condition
ConditionClose
    • Distinguished
    • Colorectal Cancer
      Dr. Gold is
      Distinguished
      . Learn about Colorectal Cancer.
      See more Colorectal Cancer experts
    • Familial Colorectal Cancer
      Dr. Gold is
      Distinguished
      . Learn about Familial Colorectal Cancer.
      See more Familial Colorectal Cancer experts
    • Familial Pancreatic Cancer
      Dr. Gold is
      Distinguished
      . Learn about Familial Pancreatic Cancer.
      See more Familial Pancreatic Cancer experts
    • Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
      Dr. Gold is
      Distinguished
      . Learn about Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET).
      See more Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) experts
    • Lynch Syndrome
      Dr. Gold is
      Distinguished
      . Learn about Lynch Syndrome.
      See more Lynch Syndrome experts
    • Neuroendocrine Tumor
      Dr. Gold is
      Distinguished
      . Learn about Neuroendocrine Tumor.
      See more Neuroendocrine Tumor experts
    • Advanced
    • Anal Cancer
      Dr. Gold is
      Advanced
      . Learn about Anal Cancer.
      See more Anal Cancer experts
    • Cholangiocarcinoma (Bile Duct Cancer)
      Dr. Gold is
      Advanced
      . Learn about Cholangiocarcinoma (Bile Duct Cancer).
      See more Cholangiocarcinoma (Bile Duct Cancer) experts
    • Fibrolamellar Carcinoma
      Dr. Gold is
      Advanced
      . Learn about Fibrolamellar Carcinoma.
      See more Fibrolamellar Carcinoma experts
    • Gallbladder Adenocarcinoma
      Dr. Gold is
      Advanced
      . Learn about Gallbladder Adenocarcinoma.
      See more Gallbladder Adenocarcinoma experts
    • Gallbladder Cancer
      Dr. Gold is
      Advanced
      . Learn about Gallbladder Cancer.
      See more Gallbladder Cancer experts
    • Gastroesophageal Junction Cancer
      Dr. Gold is
      Advanced
      . Learn about Gastroesophageal Junction Cancer.
      See more Gastroesophageal Junction Cancer experts
    View All 10 Advanced Conditions
    • Experienced
    • Agranulocytosis
      Dr. Gold is
      Experienced
      . Learn about Agranulocytosis.
      See more Agranulocytosis experts
    • Appendix Cancer
      Dr. Gold is
      Experienced
      . Learn about Appendix Cancer.
      See more Appendix Cancer experts
    • Chronic Familial Neutropenia
      Dr. Gold is
      Experienced
      . Learn about Chronic Familial Neutropenia.
      See more Chronic Familial Neutropenia experts
    • Desmoid Tumor
      Dr. Gold is
      Experienced
      . Learn about Desmoid Tumor.
      See more Desmoid Tumor experts
    • Epithelioid Sarcoma
      Dr. Gold is
      Experienced
      . Learn about Epithelioid Sarcoma.
      See more Epithelioid Sarcoma experts
    • Fibrosarcoma
      Dr. Gold is
      Experienced
      . Learn about Fibrosarcoma.
      See more Fibrosarcoma experts
    View All 14 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.